Share the Video:

Trauma and psychedelic-assisted therapy

Barbara Rothbaum, Lynnette A. Averill

Dr. Barbara Rothbaum has been researching and delivering evidence-based treatment (EBT) for PTSD since 1986. In this talk, she will enumerate the advantages of combining MDMA with prolonged exposure therapy (PE) for PTSD. PE is a well-studied, effective, well disseminated EBT with many PE trainers worldwide. PE is recommended as a first-line treatment in every published treatment guideline for PTSD. There is theoretical support for a synergistic mechanism of action for adding MDMA to PE. Translational research supports that MDMA facilitates the extinction of fear in a rodent model. In a healthy human model, more extinction recall responders were in the MDMA condition.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Couples therapy and psychedelic-assisted therapy

Dr. Anne Wagner and Dr. Michael Mithoefer discuss therapeutic potential of MDMA for couples, sharing insights from their MDMA-assisted couples therapy trials and ongoing research with Dr. Chandra Khalifian and

Chandra Khalifian, Leslie Morland, Kayla Knopp

PS2023 Health Conditions MDMA MDMA-AT Psychedelic Assisted Therapy PTSD Research and Science

Investigational MDMA-assisted therapy and eating disorder symptoms in a randomized placebo-controlled trial for severe PTSD

MDMA-assisted therapy (MDMA-AT) shows promise in treating PTSD and comorbid eating disorders. A study found significant reductions in eating disorder symptoms with MDMA-AT compared to placebo in severe PTSD patients.

Adele LaFrance, Timothy Brewerton

PS2023 Health Conditions Psilocybin Psychedelic Assisted Therapy Research and Science Therapy Ethics

Panel discussion on psilocybin therapy for cancer patients and palliative care

Dr. Smith and Dr. Jones explore the latest research on psychedelic therapy and its potential impact on mental health during the PS2023 conference.

Stacy Fischer, Anthony “Tony” Bossis, Charles S Grob, Manish Agrawal, Shoshana Ungerleider

PS2023 Cannabis Health Conditions Psychedelic Assisted Therapy PTSD Research and Science Veterans

Phase 2 Multicenter Randomized Placebo-controlled, Double-blind Study to Assess Safety/Efficacy of Inhaled Cannabis in Veterans for PTSD

Study aims to re-examine inhaled cannabis for treating PTSD, with Phase 2 study assessing high THC cannabis versus placebo for managing symptoms and pain in 360 veterans across U.S.

Sue Sisley, Shane Pennington

PS2023 Health Conditions Psychedelic Assisted Therapy Psychedelic Science Research Research and Science Therapy Ethics

Emerging research on psychedelic therapies for the treatment of pain

Neurological disorders like chronic pain and Alzheimer’s are being studied for psychedelic therapy benefits, expanding research beyond traditional mental health applications. Current studies explore potential applications for neurorehabilitation.

Julia Bornemann, James Close, Joel Castellanos, Robin Carhart-Harris

PS2023 Health Conditions MDMA Psychedelic Assisted Therapy Psychedelic Science Research Therapy Ethics

Beyond Ecstasy: Progress in Developing and Understanding a Novel Class of Therapeutic Medicine

MDMA's therapeutic mechanism differs from classical psychedelics, showing potential for treating CNS disorders. Shulgin's 1970s research inspired exploration of modifying MDMA's structure and developing novel compounds for improved effects.

Matthew Baggott

PS2023 Harm Reduction Health Conditions Ketamine Psychedelic Assisted Therapy Research and Science Therapy Ethics

Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses

KAP program offers innovative treatment for adolescents with emotional issues, focusing on family involvement. Successes and challenges of this unique approach are discussed.

Phil Wolfson

PS2023 Anxiety MDMA Psychedelic Assisted Therapy PTSD Resources for Therapists Therapy Ethics

Transformational synergies: Experiential-relational psychotherapeutic interventions can accelerate the healing of attachment trauma

MDMA optimizes brain chemistry for safety, openness, and compassion. AEDP uses relational interventions to enhance MDMA's effects in trauma therapy, fostering trust, intimacy, and healing attachment.

Kari Gleiser

PS2023 Health Conditions Psychedelic Assisted Therapy Research and Science

Laying the foundation for a new ecosystem in mental healthcare

Executives of major psychedelic drug developers discuss building infrastructure for psychedelic therapy in healthcare, including education, clinics, EMR tools, and research to enhance outcomes.

Doug Drysdale

Trauma and psychedelic-assisted therapy

Become a MAPS Member with a monthly donation

Related Videos